Core Viewpoint - RCM Technologies, Inc. reported strong financial results for the thirteen weeks ended March 29, 2025, with significant increases in revenue, gross profit, and net income compared to the prior year, indicating robust operational performance and effective investment strategies [2][3]. Financial Performance - Revenue for the current quarter was $84.5 million, a 17.4% increase from $71.9 million in the comparable prior quarter [2]. - Gross profit reached $22.0 million, reflecting a 7.9% increase from $20.4 million in the prior quarter [2]. - GAAP net income was $4.2 million, or $0.54 per diluted share, compared to $4.0 million, or $0.48 per diluted share, in the prior quarter [2]. - Adjusted EBITDA (non-GAAP) was $7.8 million, up from $6.8 million in the comparable prior quarter [2]. Operational Highlights - The company generated $16.7 million in cash flow from operations and reduced net debt by $12.0 million while retiring shares [3]. - The internal business metrics are strengthening, and the company is positioned well due to a thoughtful investment strategy [3]. Segment Performance - Revenue breakdown for the current quarter included $43.3 million from Life Sciences, $32.1 million from Specialty Health Care, and $9.0 million from Data and Solutions [16]. - Gross profit margins varied by segment, with Life Sciences at 28.2%, Specialty Health Care at 19.2%, and Data Solutions at 39.7% [16]. Upcoming Events - A conference call is scheduled for May 8, 2025, to discuss the financial results in detail [4].